Revivo Therapeutics

General Information

Company Name

Revivo Therapeutics

Founded Year

2016

Location (Offices)

Durham, United States +1

Founders / Decision Makers

Number of Employees

Industries

Health Care

Funding Stage

Social Media

Revivo Therapeutics - Company Profile

Revivo Therapeutics is a clinical stage biotechnology company based in the United States that is spearheading the development of a new class of drugs targeting cognitive decline. With their pioneering approach, their first drug candidate, RIV-5061, aims to address the treatment of Mild Cognitive Impairment. Currently, the company is in the process of raising funding for Phase 1/1b clinical trials.

Taxonomy: clinical stage, drug development, cognitive decline, small molecules, Mild Cognitive Impairment, Phase 1/1b trials, neuroscience, pharmaceuticals, cognitive enhancement

Funding Rounds & Investors of Revivo Therapeutics (0)

View All

There is no investment information

Latest News of Revivo Therapeutics

View All

No recent news or press coverage available for Revivo Therapeutics.

Similar Companies to Revivo Therapeutics

View All

Auto Train Brain EEG-based, AI-powered, reliable and mobile neurofeedback training that improves reading abilities and cognitive skills

Moodcare Moodcare is a mindfulness-based cognitive therapy app.

Braingaze Technology-driven early-stage detection and therapeutic support tools for ADHD, ASD, Alzheimer's Disease

Center for Vital Longevity Research Center at UT Dallas dedicated to pursuing research that leads to cognitive health for life.

Cognito Therapeutics, Inc. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases.

Revivo Therapeutics - Company Profile

Funding Rounds & Investors of Revivo Therapeutics (0)

Latest News of Revivo Therapeutics

Similar Companies to Revivo Therapeutics

Want to dive deeper into Revivo Therapeutics? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.